Hot Melt Extrusion and Spray Drying are two distinct technologies employed in the pharmaceutical industry to enhance drug formulations. Let’s take a closer look at these methods and compare their key features. In terms of common strong points, both Hot Melt Extrusion and Spray Drying share the goal of improving the release profile of all …
Great news: We RONDOL just won the Regional Award at Tech for Future 2023: thank you La Tribune, thank you the jury and overall thank you to RONDOL customers, RONDOL partners… and to my super team! The National final will be on March 13th in Paris: we count on your support 😀 You can find …
Tech for Future 2023 : Rondol won the regional award ! Read More »
Victoire de Margerie (CEO of Rondol), Pascal Boulet (Institut Jean Lamour), and Maël Gallas (Rondol) published a new article in SPE Polymers about our current research and development on hot-melt extrusion (HME) for drug delivery and pharmaceutical formulation. Unfortunately, a large percentage of marketed drugs (40%) and those in the development pipeline (90%) are poorly water …
11 months after we raised funds, proud to announce that we have achieved the next step team building we were aiming for. So as from September 1st: Our long-standing Senior Advisor University Partnerships Matthias Verbeet will extend his reach to key Industrial Partnerships. Our VP Global Sales & Marketing, Ines Khalfallah who joined us us …
New milestone on the RONDOL SEQENS joint cooperation to improve bioavailability of selected molecules with the successful installation of our first GMP vertical extrusion line at the SEQENS LAB in Porcheville.
Happy to receive the Trophée Initiative Chimie that highlights the potential to improve bioavailability of active principles and reduce the capital intensity of their manufacturing thanks to extrusion. Follow the link below to read the entire article. https://www.usinenouvelle.com/article/relation-fournisseur-client-palmares-haut-de-gamme-pour-la-2e-edition-des-trophees-initiatives-chimie.N1778262
Great paper in International Journal of Pharmaceutics about solutions for the pharmaceutical industry in accessing continuous manufacturing technologies and allowing for efficient utilization of resources upon scale-up and mass production during global pandemics and drug shortages. This reflects a superb common common work between RONDOL, Queens University Belfast, Birmingham School of Pharma and Institut Jean …
1st Paper in International Journal of Pharmaceutics Read More »
A great step on our road to adapting extrusion technology to the micro scale and to Pharma standards. And another major step after the Rondol BASF team was nominated at the Galien Awards in New York in October 2020, after we signed the Rondol SEQENS global technology partnership in March 2021 and after we announced …
Rondol patent for vertical extruder granted under US law Read More »
In recognition of World Malaria Day this week, we proudly announce a newly initiated research collaboration between BASF Pharma Solutions, Queen’s University Belfast, and Rondol Group with the goal of developing a model, robust, child-friendly dosage form based on anti-malarial active pharmaceutical ingredients (APIs) while using BASF excipients, hot-melt extrusion (HME) technology, and a Rondol …
Rondol cooperates with BASF and QUB against child malaria Read More »
Un an de pandémie mondiale aura fait apparaître une complémentarité flagrante entre Seqens, acteur mondial de la synthèse pharmaceutique, et Rondol , pionnier lorrain de l’extrusion à usage pharmaceutique. Le grand groupe et la PME ont débuté en mars, à Nancy, les premiers essais de micro-extrusion du glycopyrrolate, une molécule exploitée par Seqens dans le traitement de l’asthme. Ces …
Rondol initie Seqens à la micro-extrusion qui booste les principes actifs Read More »